Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 11 results

Author Title [ Type

] Year

Filters: Author is Treanor, John J [Clear All Filters]

Journal Article

El-Kamary, Samer S, Marcela F Pasetti, Paul M Mendelman, Sharon E Frey, David I Bernstein, John J Treanor, Jennifer Ferreira, et al.. 2010. “Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies And Antibody-Secreting Cells That Express Homing Receptors For Mucosal And Peripheral Lymphoid Tissues.”. J Infect Dis 202 (11). J Infect Dis: 1649-58. doi:10.1086/657087.

Ramani, Sasirekha, Frederick H Neill, Jennifer Ferreira, John J Treanor, Sharon E Frey, David J Topham, Robert R Goodwin, et al.. 2017. “B-Cell Responses To Intramuscular Administration Of A Bivalent Virus-Like Particle Human Norovirus Vaccine.”. Clin Vaccine Immunol 24 (5). Clin Vaccine Immunol. doi:10.1128/CVI.00571-16.

Belshe, Robert B, Frances K Newman, Sharon E Frey, Robert B Couch, John J Treanor, Carol O Tacket, and Lihan Yan. 2004. “Dose-Dependent Neutralizing-Antibody Responses To Vaccinia.”. J Infect Dis 189 (3). J Infect Dis: 493-7. doi:10.1086/380906.

Treanor, John J, Gilbert M Schiff, Robert B Couch, Thomas R Cate, Rebecca C Brady, Mhorag C Hay, Mark Wolff, Dewei She, and Manon MJ Cox. 2006. “Dose-Related Safety And Immunogenicity Of A Trivalent Baculovirus-Expressed Influenza-Virus Hemagglutinin Vaccine In Elderly Adults.”. J Infect Dis 193 (9). J Infect Dis: 1223-8. doi:10.1086/503050.

Zangwill, Kenneth M, John J Treanor, James D Campbell, Diana L Noah, and Jennifer Ryea. 2008. “Evaluation Of The Safety And Immunogenicity Of A Booster (Third) Dose Of Inactivated Subvirion H5N1 Influenza Vaccine In Humans.”. J Infect Dis 197 (4). J Infect Dis: 580-3. doi:10.1086/526537.

Goji, Nega Ali, Carrie Nolan, Heather Hill, Mark Wolff, Diana L Noah, Tracy B Williams, Thomas Rowe, and John J Treanor. 2008. “Immune Responses Of Healthy Subjects To A Single Dose Of Intramuscular Inactivated Influenza A/vietnam/1203/2004 (H5N1) Vaccine After Priming With An Antigenic Variant.”. J Infect Dis 198 (5). J Infect Dis: 635-41. doi:10.1086/590916.

Bernstein, David I, Robert L Atmar, Marshall G Lyon, John J Treanor, Wilbur H Chen, Xi Jiang, Jan Vinjé, et al.. 2015. “Norovirus Vaccine Against Experimental Human Gii.4 Virus Illness: A Challenge Study In Healthy Adults.”. J Infect Dis 211 (6). J Infect Dis: 870-8. doi:10.1093/infdis/jiu497.

Treanor, John J, Robert L Atmar, Sharon E Frey, Robert Gormley, Wilbur H Chen, Jennifer Ferreira, Robert Goodwin, Astrid Borkowski, Ralf Clemens, and Paul M Mendelman. 2014. “A Novel Intramuscular Bivalent Norovirus Virus-Like Particle Vaccine Candidate--Reactogenicity, Safety, And Immunogenicity In A Phase 1 Trial In Healthy Adults.”. J Infect Dis 210 (11). J Infect Dis: 1763-71. doi:10.1093/infdis/jiu337.

Brady, Rebecca C, John J Treanor, Robert L Atmar, Wendy A Keitel, Robert Edelman, Wilbur H Chen, Patricia Winokur, et al.. 2009. “Safety And Immunogenicity Of A Subvirion Inactivated Influenza A/h5N1 Vaccine With Or Without Aluminum Hydroxide Among Healthy Elderly Adults.”. Vaccine 27 (37). Vaccine: 5091-5. doi:10.1016/j.vaccine.2009.06.057.

Keitel, Wendy A, James D Campbell, John J Treanor, Emmanuel B Walter, Shital M Patel, Fenhua He, Diana L Noah, and Heather Hill. 2008. “Safety And Immunogenicity Of An Inactivated Influenza A/h5N1 Vaccine Given With Or Without Aluminum Hydroxide To Healthy Adults: Results Of A Phase I-Ii Randomized Clinical Trial.”. J Infect Dis 198 (9). J Infect Dis: 1309-16. doi:10.1086/592172.

Treanor, John J, James D Campbell, Kenneth M Zangwill, Thomas Rowe, and Mark Wolff. 2006. “Safety And Immunogenicity Of An Inactivated Subvirion Influenza A (H5N1) Vaccine.”. N Engl J Med 354 (13). N Engl J Med: 1343-51. doi:10.1056/NEJMoa055778.